Powered by

Eli Lilly starts human study of potential COVID-19 treatment

Jun 01, 2020 - Nasdaq

June 1 (Reuters) - Eli Lilly and Co LLY.N said on Monday patients have been dosed to test its potential antibody treatment designed to fight COVID-19, caused by the new coronavirus. The study will assess safety and tolerability in patients hospitalized with COVID-19 and results are anticipated by the end of June, the company said in a statement. (Reporting by Ankur Banerjee in Bengaluru; Editing by Shinjini Ganguli) (( ankur.banerjee@thomsonreuters.com ;; within U.S. +1 646 223 8780, outside ...